Cargando…

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection

Detalles Bibliográficos
Autores principales:	Anichini, Gabriele, Terrosi, Chiara, Gandolfo, Claudia, Gori Savellini, Gianni, Fabrizi, Simonetta, Miceli, Giovanni B., Cusi, M. Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063888/ https://www.ncbi.nlm.nih.gov/pubmed/33852796 http://dx.doi.org/10.1056/NEJMc2103825

Ejemplares similares

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine
por: Anichini, Gabriele, et al.
Publicado: (2022)

Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy
por: Anichini, Gabriele, et al.
Publicado: (2020)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID
por: Cusi, Maria Grazia, et al.
Publicado: (2023)

Comparative Performance of a New SARS-CoV-2 Rapid Detection System
por: Gori Savellini, Gianni, et al.
Publicado: (2021)

Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream
por: Gandolfo, Claudia, et al.
Publicado: (2022)

Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED Light
por: Terrosi, Chiara, et al.
Publicado: (2021)

SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
por: Gori Savellini, Gianni, et al.
Publicado: (2021)

Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion
por: Gori Savellini, Gianni, et al.
Publicado: (2022)

Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
por: Gandolfo, Claudia, et al.
Publicado: (2022)

Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation
por: Gori Savellini, Gianni, et al.
Publicado: (2019)

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
por: Gandolfo, Claudia, et al.
Publicado: (2021)

SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells
por: Gori Savellini, Gianni, et al.
Publicado: (2023)

How long can SARS-CoV-2 persist in human corpses?
por: Gabbrielli, Mario, et al.
Publicado: (2021)

Ubiquitin and Not Only Unfolded Domains Drives Toscana Virus Non-Structural NSs Protein Degradation
por: Gori Savellini, Gianni, et al.
Publicado: (2020)

Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience
por: Cusi, Maria Grazia, et al.
Publicado: (2021)

Infectious Toscana Virus in Seminal Fluid of Young Man Returning from Elba Island, Italy
por: Matusali, Giulia, et al.
Publicado: (2022)

Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020
por: Cusi, Maria Grazia, et al.
Publicado: (2020)

Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein
por: De Angelis, Marta, et al.
Publicado: (2023)

Hot Climate and Humidity Do Not Interfere with BA.5 Omicron Spreading
por: Cusi, Maria Grazia, et al.
Publicado: (2023)

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?
por: Piralla, Antonio, et al.
Publicado: (2021)

Human bocavirus detection in an atopic child affected by pneumonia associated with wheezing
por: Terrosi, Chiara, et al.
Publicado: (2007)

Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia
por: Fezaa, Ons, et al.
Publicado: (2014)

Toscana Virus Epidemiology: From Italy to Beyond
por: Cusi, Maria G, et al.
Publicado: (2010)

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
por: Di Giacomo, Anna M., et al.
Publicado: (2022)

Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects
por: Cusi, Maria Grazia, et al.
Publicado: (2010)

RSV and HMPV seroprevalence in Tuscany (Italy) and North‐Rhine Westfalia (Germany) in the winter season 2009/2010
por: Cusi, Maria G., et al.
Publicado: (2011)

Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay
por: Gandolfo, Claudia, et al.
Publicado: (2021)

Beyond the Biological Effect of a Chemically Characterized Poplar Propolis: Antibacterial and Antiviral Activity and Comparison with Flurbiprofen in Cytokines Release by LPS-Stimulated Human Mononuclear Cells
por: Governa, Paolo, et al.
Publicado: (2019)

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020)

Maintenance doses for clozapine: past and present
por: Sharma, Avneet
Publicado: (2018)

Endoscopy during the COVID-19 pandemic: Is it time to down-grade personal protective equipment for vaccinated personnel?
por: Elli, Luca, et al.
Publicado: (2021)

Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis
por: Türkoğlu, Recai, et al.
Publicado: (2022)

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
por: Mamez, Anne-Claire, et al.
Publicado: (2021)

Treatment and outcomes of POEMS syndrome: changes in the past 20 years
por: Yu, Yan-ying, et al.
Publicado: (2021)

Analysis of the Impact Factor of Emergency Medicine Journals in the Past 10 Years
por: Liang, Yang, et al.
Publicado: (2016)

SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection
por: Kang, Yu Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rchcf97oge1n7ue57ivs05fqjl